SCHEMBL12374382

SCHEMBL12374382

CCCCc1ccc(-c2c(-c3ccc(CCCC)cc3)c(C)c3nsnc3c2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.45
▸ RARB P10826 3/20 0.41
▸ RAB9A P51151 5/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ NISCH Q9Y2I1 1/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CA2 P00918 2/20 0.39
▸ CA1 P00915 1/20 0.39
▸ PLK1 P53350 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ NFKB1 P19838 2/20 0.38
▸ NFKB2 Q00653 2/20 0.38
▸ RELA Q04206 2/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12696163 0.80 HSD11B1 (0.44) HSD11B1RARBRAB9AKDM4ENISCH
SCHEMBL12374384 0.79 CYP2D6 (0.50) RAB9AKDM4ESMN1; SMN2NPC1HSD17B10
SCHEMBL18462105 0.77 HSD11B1 (0.40) HSD11B1RARBRAB9AKDM4ENISCH
SCHEMBL17694336 0.74 KDM4E (0.48) HSD11B1RARBRAB9AKDM4ESMN1; SMN2
SCHEMBL5551587 0.72 RARB (0.67) HSD11B1RARBRAB9AKDM4ENISCH
SCHEMBL28829434 0.72 RARB (0.67) HSD11B1RARBRAB9AKDM4ENISCH
SCHEMBL18407713 0.71 HSD11B1 (0.45) HSD11B1RARBRAB9ANISCHSMN1; SMN2
SCHEMBL7926844 0.70 HSD11B1 (0.51) HSD11B1RARBRAB9AKDM4ENISCH
SCHEMBL28900119 0.70 RARB (0.64) HSD11B1RARBRAB9AKDM4ENISCH
SCHEMBL862297 0.70 GCGR (0.50) RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9331284-B2 Polymer compound and light-emitting device using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-05-03 — — US disclosed
US-20120326140-A1 POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2012-12-27 — — US disclosed
US-20110187266-A1 POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326140-A1 POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME CCNA1, CCNB1, CCNL2 HSD11B1 2319/4885RARB 1671/4885RAB9A 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback